The exit comes as Trenkle accepts his new position at Novo Ventures, the venture capital arm of Novo Holdings.
Courtesy of LinkedIn Jim Trenkle announced his departure from the French corporate venture firm Sanofi Ventures, the corporate arm of pharmaceutical conglomerate Sanofi. Trenkle will work as a partner for Denmark-based venture capital firm Novo Ventures, a subsidiary of Novo Holdings, which is part of global medical treatment foundation Novo Nordisk Foundation. “After a wonderful…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
